GlassScriptPhysician profile
Gabriel Sardi
NPI 1326255712
$5,358.35
in general payments reported to CMS, 2019-2025
27 companies · $1,322 in 2025
The $1,322 reported for 2025 was more than what 76% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $619 · 2020: $527 · 2021: $696 · 2022: $552 · 2023: $608 · 2024: $1,033 · 2025: $1,322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,964.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,963.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $960.92 | 2019-2025 | Lifevest |
| Medtronic, INC. | $687.42 | 2021-2025 | Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan, Micra |
| Shockwave Medical, INC | $410.95 | 2025 | |
| Amgen INC. | $361.13 | 2019-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $360.58 | 2019-2025 | |
| Boston Scientific Corporation | $336.87 | 2019-2025 | Avvigo Guidance System |
| Edwards Lifesciences Corporation | $297.50 | 2025 | Sapien 3 Ultra Resilia |
| Pfizer INC. | $256.74 | 2019-2025 | |
| Abbott Laboratories | $251.78 | 2019-2025 | Assurity |
| Astrazeneca Pharmaceuticals LP | $228.49 | 2020-2024 | Brilinta, Farxiga |
| Medtronic Vascular, INC. | $188.64 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $132.37 | 2019-2025 | Eliquis |
| Scpharmaceuticals INC. | $125.29 | 2024 | |
| Janssen Pharmaceuticals, INC | $121.00 | 2019-2022 | |
| Abiomed | $113.91 | 2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $98.71 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
| Irhythm Technologies, INC. | $84.03 | 2020-2024 | Zio Monitor, Zio Xt Patch |
| Chiesi USA, INC. | $82.43 | 2021 | |
| Ge Healthcare | $46.90 | 2021-2023 | |
| Terumo Medical Corporation | $46.41 | 2020-2025 | Metacross Otw |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.70 | 2022-2024 | Jardiance |
| Acist Medical Systems, INC. | $32.81 | 2024 | |
| Kestra Medical Technology Services, INC. | $21.02 | 2025 | Assure Wcd |
| Sanofi-Aventis U.S. LLC | $19.24 | 2019 | |
| Elutia, INC. | $17.27 | 2021 | |
| Tactile Systems Technology INC | $16.72 | 2025 | Nimbl, Flexitouch Plus |
| Lexicon Pharmaceuticals, INC. | $16.52 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gabriel Sardi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.